Literature DB >> 9581564

The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

D Legrand1, P H van Berkel, V Salmon, H A van Veen, M C Slomianny, J H Nuijens, G Spik.   

Abstract

We previously characterized a 105 kDa receptor for human lactoferrin (hLf) on Jurkat human lymphoblastic T-cells. To delineate the role of the basic cluster Arg2-Arg3-Arg4-Arg5 of hLf in the interaction with Jurkat cells, we isolated N-terminally deleted hLf species of molecular mass 80 kDa lacking two, three or four N-terminal residues (hLf-2N, hLf-3N and hLf-4N) from native hLf that had been treated with trypsin. Native hLf bound to 102000 sites on Jurkat cells with a dissociation constant (Kd) of 70 nM. Consecutive removal of N-terminal arginine residues from hLf progressively increased the binding affinity but decreased the number of binding sites on the cells. A recombinant hLF mutant lacking the first five N-terminal residues (rhLf-5N) bound to 17000 sites with a Kd of 12 nM. The binding parameters of bovine lactoferrin (Lf) and native hLf did not significantly differ, whereas the binding parameters of murine Lf (8000 sites; Kd 30 nM) resembled those of rhLf-5N. Culture of Jurkat cells in the presence of chlorate, which inhibits sulphation, decreased the number of binding sites for both native hLf and hLf-3N but not for rhLf-5N, indicating that the hLf-binding sites include sulphated molecules. We propose that the interaction of hLf with a large number of binding sites (approx. 80000 per cell) on Jurkat cells is dependent on Arg2-Arg3-Arg4, but not on Arg5. Interaction with approx. 20000 binding sites per cell, presumably the hLf receptor, does not require the first N-terminal basic cluster of hLf. Moreover, the affinity of hLf for the latter binding site is enhanced approx. 6-fold after removal of the first basic cluster. Thus N-terminal proteolysis of hLf in vivo might serve to modulate the nature of its binding to cells and thereby its effects on cellular physiology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9581564      PMCID: PMC1218865          DOI: 10.1042/bj3270841

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  [Preparation and properties of lactosiderophilin (lactotransferrin) of human milk].

Authors:  J MONTREUIL; J TONNELAT; S MULLET
Journal:  Biochim Biophys Acta       Date:  1960-12-18

2.  Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line.

Authors:  B Y Bi; J L Liu; D Legrand; A C Roche; M Capron; G Spik; J Mazurier
Journal:  Eur J Cell Biol       Date:  1996-03       Impact factor: 4.492

3.  Characterization of human lactoferrin produced in the baculovirus expression system.

Authors:  V Salmon; D Legrand; B Georges; M C Slomianny; B Coddeville; G Spik
Journal:  Protein Expr Purif       Date:  1997-03       Impact factor: 1.650

4.  Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.

Authors:  P H van Berkel; M E Geerts; H A van Veen; P M Kooiman; F R Pieper; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

5.  Isolation of lactoferrin from human whey by a single chromatographic step.

Authors:  L Bläckberg; O Hernell
Journal:  FEBS Lett       Date:  1980-01-14       Impact factor: 4.124

6.  Primary structure of the glycans from human lactotransferrin.

Authors:  G Spik; G Strecker; B Fournet; S Bouquelet; J Montreuil; L Dorland; H van Halbeek; J F Vliegenthart
Journal:  Eur J Biochem       Date:  1982-01

7.  Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

Authors:  E Elass-Rochard; A Roseanu; D Legrand; M Trif; V Salmon; C Motas; J Montreuil; G Spik
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

8.  Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells.

Authors:  D Legrand; V Salmon; B Coddeville; M Benaissa; Y Plancke; G Spik
Journal:  FEBS Lett       Date:  1995-05-22       Impact factor: 4.124

9.  Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.

Authors:  H Q Miao; R Ishai-Michaeli; R Atzmon; T Peretz; I Vlodavsky
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

10.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

View more
  17 in total

1.  The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.

Authors:  Ellen A J Thomassen; Harrie A van Veen; Patrick H C van Berkel; Jan H Nuijens; Jan Pieter Abrahams
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

2.  Evaluation of the protective effect of bovine lactoferrin against lipopolysaccharides in a bovine mammary epithelial cell line.

Authors:  Chiara Pecorini; Davide Sassera; Raffaella Rebucci; Francesca Saccone; Claudio Bandi; Antonella Baldi
Journal:  Vet Res Commun       Date:  2010-03-30       Impact factor: 2.459

Review 3.  Immunomodulatory effects of lactoferrin.

Authors:  Tania Siqueiros-Cendón; Sigifredo Arévalo-Gallegos; Blanca Flor Iglesias-Figueroa; Isui Abril García-Montoya; José Salazar-Martínez; Quintín Rascón-Cruz
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

4.  Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.

Authors:  E Elass-Rochard; D Legrand; V Salmon; A Roseanu; M Trif; P S Tobias; J Mazurier; G Spik
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.

Authors:  P H van Berkel; M E Geerts; H A van Veen; M Mericskay; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

6.  Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.

Authors:  S Baveye; E Elass; D G Fernig; C Blanquart; J Mazurier; D Legrand
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 8.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes.

Authors:  A Denys; F Allain; M Carpentier; G Spik
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.